Preliminary scientific tests show conolidine might inhibit unique ion channels, reducing neuronal excitability and restricting pain indicators. This mechanism is especially suitable in neuropathic soreness, exactly where abnormal signaling leads to persistent distress. Also, conolidine appears to affect G protein-coupled receptor (GPCR) pathways in